Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $10

Benzinga Newsdesk www.benzinga.com Negative 76.5%

Neg 76.5% Neu 0% Pos 0%

Canaccord Genuity analyst George Gianarikas maintains Enovix (NASDAQ:ENVX) with a Buy and lowers the price target from $15 to $10.